Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Cardiac Failure

3,4-methylenedioxyamphetamine has been researched along with Cardiac Failure in 2 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Metra, M1
Coats, AJS1

Other Studies

2 other studies available for 3,4-methylenedioxyamphetamine and Cardiac Failure

ArticleYear
Why we love heart failure: an introduction to the universal definition of heart failure.
    European journal of heart failure, 2021, Volume: 23, Issue:3

    Topics: Heart Failure; Humans; Love

2021
Can you die of a broken heart? For some, the stress of grief causes serious heart problems.
    Harvard heart letter : from Harvard Medical School, 2013, Volume: 23, Issue:6

    Topics: Anxiety; Grief; Health Status; Heart Failure; Humans; Interpersonal Relations; Love; Stress, Psychol

2013